Conquering absolute contraindications to transplantation: Positive-crossmatch and ABO-incompatible kidney transplantation

Surgery

Volumn 137, Issue 3, 2005, Pages 269-273

  Dean, Patrick G ^a   Gloor, James M ^a   Stegall, Mark D ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; ALLOANTIBODY; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ANTIBODY TITER; ANTIGEN EXPRESSION; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD SAMPLING; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG MEGADOSE; FEASIBILITY STUDY; GRAFT DYSFUNCTION; GRAFT REJECTION; HEALTH PROGRAM; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; PLASMAPHERESIS; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; RISK ASSESSMENT; SPLENECTOMY; TREATMENT CONTRAINDICATION;

EID: 14644411705     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2004.08.002     Document Type: Article

References (14)

1. H.M. Gebel, and R.A. Bray Sensitization and sensitivity: defining the unsensitized patient Transplantation 69 2000 1370 1374
2. M.D. Stegall, P.G. Dean, M.A. McBride, and J.J. Wynn Organ Procurement and Transplantation Network/United Network for Organ Sharing Kidney/Pancreas Transplantation Committee. Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era Transplantation 74 2002 670 675
3. S.C. Jordan, A. Vo, S. Bunnapradist, M. Toyoda, A. Peng, and D. Puliyanda Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients Transplantation 76 2003 631 636
4. R.A. Montgomery, A.A. Zachary, L.C. Racusen, M.S. Leffell, K.E. King, and J. Burdick Plasmapheresis and intravenous immunoglobulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match positive recipients Transplantation 70 2000 887 895
5. A.A. Zachary, R.A. Montgomery, L.E. Ratner, M. Samaniego-Picota, M. Haas, and D. Kopchaliiska Specific and durable elimination of antibody to donor HLA antigens in renal transplant recipients Transplantation 76 2003 1519 1525
6. E.J. Schweitzer, J.S. Wilson, M. Fernandez-Vina, M. Fox, M. Gutierrez, and A. Wiland A high panel-reactive antibody rescue protocol for crossmatch-positive live donor kidney transplants Transplantation 70 2000 1531 1536
7. J.M. Gloor, S.R. DeGoey, A.A. Pineda, S.B. Moore, M. Prieto, and S.L. Nyberg Overcoming a positive crossmatch Am J Transplant 3 2003 1017 1023
8. K. Takahashi, K. Saito, S. Takahara, A. Okuyama, K. Tanabe, and H. Toma Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan Am J Transplant 4 2004 1089 1096
9. P. Schnuelle, and F.J. van der Woude Should A2 kidneys be transplanted into B or O recipients? Lancet 351 1998 1675 1676
10. A.M. Alkhunaizi, A.M. de Mattos, J.M. Barry, W.M. Bennett, and D.J. Norman Renal transplantation across the ABO barrier using A2 kidneys Transplantation 67 1999 1319 1324
11. J.B. Sorensen, W.J. Grant, L.P. Belnap, J. Stinson, and T.C. Fuller Transplantation of ABO group A2 kidneys from living donors into group O and B recipients Am J Transplant 1 2001 296 299
12. J.M. Gloor, D.J. Lager, S.B. Moore, A.A. Pineda, M.E. Fidler, and T.S. Larson ABO-incompatible kidney transplantation using both A2 and non-A2 living donors Transplantation 75 2003 971 977
13. W.D. Park, J.P. Grande, D. Ninova, K.A. Nath, J.L. Platt, and J.M. Gloor Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury Am J Transplant 3 2003 952 960
14. Y. Lin, M.P. Soares, K. Sato, K. Takigami, E. Csizmadia, and N. Smith Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts J Immunol 163 1999 2850 2857